2025-10-30
Financial Times
6 related
Life sciences group Thermo Fisher agrees to acquire PE-owned drug trial software maker Clario for $9.4B in an all-cash deal expected to close by mid-2026
Oliver Barnes / Financial Times :
Loading articles...